Wednesday, November 18, 2026

Pharmaceutical

Global pharmaceutical developments, drug approvals, biotechnology breakthroughs, and safety.

Breaking AlertPharmaceuticalabout 17 hours ago

FDA Grants Accelerated Approval for First-in-Class Targeted Oncology Therapy for Advanced Solid Tumors

The U.S. FDA has finalized an accelerated approval pathway for a novel dual-mechanism kinase inhibitor, opening treatment avenues for refractory solid tumors with specific genetic alterations.

4 min read•1420 views
Advertisement
Responsive Leaderboard Ad Unit (728 × 90 / 970 × 250)Google AdSense • Compliant Biopharma & MedTech Placement